Exelixis
EXEL
#1458
Rank
HK$116.39 B
Marketcap
HK$469.73
Share price
1.42%
Change (1 day)
58.22%
Change (1 year)
Exelixis, Inc. is an American genomics-based drug discovery company and the producer of Cometriq, a treatment for medullary thyroid cancer.

Earnings for Exelixis (EXEL)

Earnings in 2026 (TTM): HK$8.08 Billion

According to Exelixis's latest financial reports the company's current earnings are HK$2.43 Billion. In 2025 the company made an earning of HK$7.38 Billion, an increase over its 2024 earnings that were of HK$5.34 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Exelixis from 2000 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) HK$8.08 B9.52%
2025 HK$7.38 B38.08%
2024 HK$5.34 B164.69%
2023 HK$2.02 B9.89%
2022 HK$1.83 B-20.33%
2021 HK$2.30 B124.82%
2020 HK$1.02 B-67.14%
2019 HK$3.12 B-11.94%
2018 HK$3.54 B185.09%
2017 HK$1.24 B-325.82%
2016 -HK$0.56 Billion-58.12%
2015 -HK$1.32 Billion-37.61%
2014 -HK$2.11 Billion9.75%
2013 -HK$1.93 Billion65.96%
2012 -HK$1.16 Billion-291.63%
2011 HK$0.60 B-195.59%
2010 -HK$0.64 Billion-42.17%
2009 -HK$1.1 Billion-18.98%
2008 -HK$1.35 Billion-6.99%
2007 -HK$1.46 Billion46.3%
2006 -HK$1 Billion33.25%
2005 -HK$0.75 Billion-30.92%
2004 -HK$1.08 Billion44.29%
2003 -HK$0.75 Billion12.86%
2002 -HK$0.67 Billion22.79%
2001 -HK$0.54 Billion60.14%
2000 -HK$0.34 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
HK$205.65 B 2,431.02%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
HK$54.20 B 567.04%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
HK$80.72 B 893.46%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
HK$56.18 B 591.50%๐Ÿ‡ซ๐Ÿ‡ท France
Merck
MRK
HK$60.34 B 642.66%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
HK$93.46 B 1,050.20%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
HK$61.91 B 661.93%๐Ÿ‡ฌ๐Ÿ‡ง UK
Curis
CRIS
-HK$66.3 Million-100.82%๐Ÿ‡บ๐Ÿ‡ธ USA
AVEO Oncology
AVEO
-HK$0.23 Billion-102.80%๐Ÿ‡บ๐Ÿ‡ธ USA